Lobe Sciences Ltd. (CVE:LOBE)

PRESS RELEASE

published on 04/21/2026 at 12:00, 2 months 22 days ago

Lobe Sciences Ltd. Engages Massive Intelligence Pty Ltd for Investor Relations and Corporate Communications Services
Lobe Sciences engages Massive Intelligence for investor relations and corporate communications services. Massive Intelligence to provide promotional services via social media, email, and press releases

Investor Relations Biopharmaceutical Corporate Communications Lobe Sciences Massive Intelligence
BRIEF

published on 04/20/2026 at 12:05, 2 months 23 days ago

Lobe Sciences finalise un placement privé et publie une mise à jour de ses activités

Placement Privé Investissement Biopharmaceutique Sciences Du Lobe Traitement De La Drépanocytose Développement Du S-100
BRIEF

published on 04/20/2026 at 12:05, 2 months 23 days ago

Lobe Sciences Completes Private Placement and Provides Corporate Update

Private Placement Biopharmaceutical Investment Lobe Sciences Sickle Cell Treatment S-100 Development
PRESS RELEASE

published on 04/20/2026 at 12:00, 2 months 23 days ago

Lobe Sciences Ltd. Announces Closing of Non-Brokered Private Placement and Provides Corporate Update
Lobe Sciences Ltd. announces closing of non-brokered private placement offering to advance S-100 drug candidate for sickle cell disease treatment

Private Placement Biopharmaceutical Sickle Cell Disease Lobe Sciences Ltd. S-100 Drug Candidate
BRIEF

published on 04/11/2026 at 02:05, 3 months 2 days ago

Lobe Sciences Ltd. annonce un placement privé de 950 000 $

Financement Placement Privé Canada Approbations Réglementaires Lois Sur Les Valeurs Mobilières
BRIEF

published on 04/11/2026 at 02:05, 3 months 2 days ago

Lobe Sciences Ltd. Announces Private Placement for $950,000

Private Placement Funding Canada Securities Laws Regulatory Approvals
PRESS RELEASE

published on 04/11/2026 at 02:00, 3 months 2 days ago

Lobe Sciences Ltd. Announces Non-Brokered Private Placement
Lobe Sciences Ltd. announces non-brokered private placement offering to raise approximately $950,000 for working capital and corporate expenses. Focus on neurology and psychiatry therapies

Private Placement Psychiatry Neurology Thérapies Lobe Sciences Ltd.
BRIEF

published on 03/25/2026 at 13:25, 3 months 19 days ago

Lobe Sciences Ltd. Enhances Financial Stability

Shareholder Value Debt Reduction Financial Stability Strategic Restructuring Subsidiary Model
BRIEF

published on 03/25/2026 at 13:25, 3 months 19 days ago

Lobe Sciences Ltd. renforce sa stabilité financière

Valeur Actionnariale Réduction De La Dette Restructuration Stratégique Stabilité Financière Modèle De Filiale
PRESS RELEASE

published on 03/25/2026 at 13:20, 3 months 19 days ago

Lobe Sciences Ltd. Reports Improved Financial Position and Strategic Update
Lobe Sciences Ltd. significantly improves financial position: liabilities down 81%, cash up 24x, net working capital up $6.1M, outstanding warrants down 70%, and strengthened the balance sheet and capital structure

Financial Position Balance Sheet Capital Structure Strategic Update Lobe Sciences Ltd.

Published on 07/13/2026 at 21:35, 8 minutes ago

ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 1 hour 43 minutes ago

IBC Announces Share-Based Compensation to Directors
Published on 07/13/2026 at 19:30, 2 hours 13 minutes ago

NioCorp to Appear on CNBC's "Squawk Box Asia" Program Today at 8:30 p.m. ET
Published on 07/13/2026 at 15:27, 6 hours 16 minutes ago

As Ebola Spreads in Two More Provinces, NanoViricides Has Received National Ethics Committee Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in Congo
Published on 07/13/2026 at 15:10, 6 hours 33 minutes ago

iFabric Corp. Announces Launch of Aura Scrubs at U.S. National Mass Retailer

View all ACCESSWIRE

Published on 07/13/2026 at 21:20, 22 minutes ago

Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 21:17, 25 minutes ago

EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 20:48, 54 minutes ago

EQS-Adhoc: Gateway Real Estate AG: Forecast for the financial year 2026
Published on 07/13/2026 at 20:23, 1 hour 19 minutes ago

EQS-Adhoc: TRATON SE: Preliminary operating result for Q2 2026 exceeds market expectations
Published on 07/13/2026 at 20:03, 1 hour 39 minutes ago

EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures H1 2026: Net sales strongly up, earnings significantly above the prior year – positive earnings outlook

View all EQS

Published on 07/13/2026 at 18:00, 3 hours 43 minutes ago

CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 3 hours 43 minutes ago

PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 3 hours 43 minutes ago

THERMADOR GROUPE : 2026 half-year turnover
Published on 07/13/2026 at 18:00, 3 hours 43 minutes ago

THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
Published on 07/13/2026 at 17:45, 3 hours 58 minutes ago

Weekly share buyback

View all LES ECHOS COMFI WIRE

News